2014 Nuclear Medicine & Molecular Imaging News
Stanford Publishes First Clinical Paper Reporting the Use of Simultaneous PET/MRI with Time-of-flight Capability in Cancer Patients
December 23, 2014
A group of collaborators from MIPS, MRI and Nuclear Medicine sections in the Department of Radiology at Stanford University published the first clinical paper reporting the use of a novel simultaneous PET/MRI scanner with time-of-flight capability in cancer patients. Data was collected using a scanner produced by GE Healthcare and installed first worldwide at Stanford. The initial experience with this PET/MR system has shown that the TOF PET is capable of excellent performance during simultaneous PET/MR with routine pulse sequences. MR imaging was not compromised. This opens a new world of collaborations to advance science across multiple specialties. An image from this article is featured on the cover of the January 2015 issue of Clinical Nuclear Medicine (official journal of the American College of Nuclear Medicine).
Dr. Iagaru Promoted to Associate Professor
July 9, 2014
Andrei Iagaru, MD was promoted to Associate Professor.
Congratulations, Dr. Iagaru!
Carcinoid Cancer Foundation Awards Grant to Stanford University
The Carcinoid Cancer Foundation has awarded a grant of more than $65,000 to Stanford University to expand access to its Gallium-68 (Ga-68) DOTA-TATE PET/CT program for carcinoid and neuroendocrine tumor (NET) patients with somatostatin receptor positive tumors. PET imaging using the Ga-68 labeled compound DOTA-TATE offers higher resolution and sensitivity than Octreoscan®, at a lower cost, and with improved convenience for patients. Andrei Iagaru, MD, Associate Professor of Radiology and Co-Chief of the Division of Nuclear Medicine and Molecular Imaging at Stanford University Medical Center, is the Principal Investigator of the study.
The Division of Nuclear Medicine is grateful to the foundation and to the private donor for the funding. Read the full article, on The Carcinoid Cancer Foundation website, here.
Dr. Tatianie Jackson, Nuclear Medicine & Molecular Imaging Chief Resident, elected to the board of the Nuclear Medicine Resident Organization
June 25, 2014
Tatianie Jackson, MD has been elected as a board member of the Nuclear Medicine Resident Organization (NMRO). As a member of the board, Dr. Jackson will work to broaden awareness across specialties for our nuclear medicine residents, while also providing them continued education focused on specific specialty needs.
Dr. Tatianie Jackson, Nuclear Medicine & Molecular Imaging Chief Resident, received a Travel Grant at the 2014 SNMMI Mid-Winter Meeting
February 6, 2014
Tatianie Jackson, MD has received the Travel Grant at the ACNM Annual Meeting and SNMMI Mid-Winter Meting in Palm Springs, CA, for her work on "Combined NaF and FDG PET/CT Evaluation of Sarcoma Patients." This is a great achievement, as there were more than 40 presenters this year.
Congratulations, Dr. Jackson!
Dr. McDougall Received the Light of Life Award
January 31, 2014
Ross McDougall, MD has received the Light of Life Award from Memorial Sloan Kettering Cancer Center where he gave a lecture entitled, "Differentiated Thyroid Cancer, Then and Now: Four Questions and a Quandary".
The Light of Life Award is an annual award presented to an esteemed physician in thyroid cancer research as selected by the Light of Life Foundation. Their mission is to improve the quality of life of thyroid cancer patients through continual education of the lay public and the medical community, and by promoting research and development to improve thyroid cancer care. The Light of Life Foundation Honorary Award has become recognized amongst the worldwide thyroid cancer medical community.
Congratulations, Dr. McDougall!